Quinolone-resistant Shigella flexneri Isolated in a Patient Who Travelled to India
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
We report a recent case in which ciprofloxacin-resistant Shigella flexneri was isolated from a 23-yr-old female patient with a history of travel to India. Prior to her admission to our internal medicine department, she experienced symptoms of high fever and generalized weakness from continuous watery diarrhea that developed midway during the trip. S. flexneri was isolated from the stool culture. Despite initial treatment with ciprofloxacin, the stool cultures continued to show S. flexneri growth. In the susceptibility test for antibiotics of the quinolone family, the isolate showed resistance to ciprofloxacin(minimum inhibitory concentration [MIC], 8 μg/mL), norfloxacin (MIC, 32 μg/mL), ofloxacin (MIC, 8 μg/mL),nalidixic acid (MIC, 256 μg/mL), and intermediate resistance to levofloxacin (MIC, 4 μg/mL). In molecular studies for quinolone resistance related genes, plasmid borne-quinolone resistance genes such as qnrA, qnrB, qnrS, aac(6’)-Ib-cr, qepA, and oqxAB were not detected. Two mutations were observed in gyrA (248C→T, 259G→A) and 1 mutation in parC (239G→T). The molecular characteristics of the isolated S. flexneri showed that the isolate was more similar to the strains isolated from the dysentery outbreak in India than those isolated from Korea.
Abstract
We report a recent case in which ciprofloxacin-resistant Shigella flexneri was isolated from a 23-yr-old female patient with a history of travel to India. Prior to her admission to our internal medicine department, she experienced symptoms of high fever and generalized weakness from continuous watery diarrhea that developed midway during the trip. S. flexneri was isolated from the stool culture. Despite initial treatment with ciprofloxacin, the stool cultures continued to show S. flexneri growth. In the susceptibility test for antibiotics of the quinolone family, the isolate showed resistance to ciprofloxacin(minimum inhibitory concentration [MIC], 8 μg/mL), norfloxacin (MIC, 32 μg/mL), ofloxacin (MIC, 8 μg/mL),nalidixic acid (MIC, 256 μg/mL), and intermediate resistance to levofloxacin (MIC, 4 μg/mL). In molecular studies for quinolone resistance related genes, plasmid borne-quinolone resistance genes such as qnrA, qnrB, qnrS, aac(6’)-Ib-cr, qepA, and oqxAB were not detected. Two mutations were observed in gyrA (248C→T, 259G→A) and 1 mutation in parC (239G→T). The molecular characteristics of the isolated S. flexneri showed that the isolate was more similar to the strains isolated from the dysentery outbreak in India than those isolated from Korea.
참고문헌 (15)
- Haukka K, "Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers", Epidemiol Infect, 136, pp.476~482 (2008)
- Salam MA, "Antimicrobial therapy for shigellosis", Rev Infect Dis, 13(S4), pp.S332~S341 (1991)
- Swapan Kumar Niyogi, "Shigellosis", The Journal of Microbiology, 43(2), pp.133~143 (2005), 한국미생물학회
- Taneja N, "Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India", J Clin Microbiol, 45, pp.678~679 (2007)
- Kuo CY, "Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004", J Microbiol Immunol Infect, 41, pp.107~111 (2008)
- Kim JY, "Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea", Clin Microbiol Infect, 14, pp.760~765 (2008)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing, In Eighteenth Informational supplement, M100-S16", Clinical and Laboratory Standards Institute, ~ (2008)
- Morgan-Linnell SK, "Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates", Antimicrob Agents Chemother, 53, pp.235~241 (2009)
- Komp Lindgren P, "Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections", Antimicrob Agents Chemother, 47, pp.3222~3232 (2003)
- Kim HB, "oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae", Antimicrob Agents Chemother, 53, pp.3582~3584 (2009)
- Giulietti A, "An overview of real-time quantitative PCR: applications to quantify cytokine gene expression", Methods, 25, pp.386~401 (2001)
- Drlica K, "DNA gyrase, topoisomerase IV, and the 4-quinolones", Microbiol Mol Biol Rev, 61, pp.377~392 (1997)
- Poole K, "Efflux-mediated multiresistance in Gram-negative bacteria", Clin Microbiol Infect, 10, pp.12~26 (2004)
- Jacoby G, "qnr Gene nomenclature", Antimicrob Agents Chemother, 52, pp.2297~2299 (2008)
- Pazhani GP, "Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India", J Med Microbiol, 57, pp.856~863 (2008)